A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(168 sites)

United States

Southern Cancer Center (SCC) ( Site 8000), Daphne, Alabama

The University of Arizona Cancer Center - North Campus ( Site 0055), Tucson, Arizona

Los Angeles Hematology Oncology Medical Group ( Site 0026), Los Angeles, California

Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach, California

St. Marys Hospital and Regional Medical Center-SCL Health Cancer Centers of Colorado ( Site 0021), Grand Junction, Colorado

Medical Oncology Hematology Consultants (MOHC) ( Site 8002), Newark, Delaware

Comprehensive Hematology Oncology ( Site 0060), St. Petersburg, Florida

Baptist Health Lexington ( Site 0050), Lexington, Kentucky

Baptist Health Hamburg ( Site 0071), Lexington, Kentucky

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack, New Jersey

Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick, New Jersey

Presbyterian Kaseman Hospital ( Site 0072), Albuquerque, New Mexico

University of New Mexico Comprehensive Cancer Center ( Site 0047), Albuquerque, New Mexico

Presbyterian Rust Jorgensen Cancer ( Site 0073), Rio Rancho, New Mexico

Optum Medical Care, PC ( Site 0009), Westbury, New York

Novant Health Cancer Institute ( Site 0019), Charlotte, North Carolina

Novant Health Oncology Specialists ( Site 0074), Winston-Salem, North Carolina

TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0020), Cincinnati, Ohio

University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0058), Pittsburgh, Pennsylvania

Cancer Care Associates Of York ( Site 0063), York, Pennsylvania

SCRI Oncology Partners ( Site 7000), Nashville, Tennessee

Tennessee Oncology, PLLC ( Site 0068), Nashville, Tennessee

Texas Oncology - DFW ( Site 8003), Dallas, Texas

JPS Health Network ( Site 0067), Fort Worth, Texas

Texas Oncology - Gulf Coast ( Site 8006), Houston, Texas

Oncology Consultants P.A. ( Site 0061), Houston, Texas

Texas Oncology - Central/South Texas ( Site 8005), McAllen, Texas

Mays Cancer Center ( Site 0049), San Antonio, Texas

Virginia Oncology Associates (VOA) ( Site 8001), Norfolk, Virginia

Shenandoah Oncology ( Site 8004), Winchester, Virginia

Northwest Medical Specialties, PLLC ( Site 0062), Tacoma, Washington

Circuit Clinical/SSM Health Dean Medical Group ( Site 0039), Madison, Wisconsin

Argentina

Hospital Aleman ( Site 0200), Ciudad Autonoma de Buenos Aires, Buenos Aires

Instituto de Investigaciones Clínicas Mar del Plata ( Site 0205), Mar del Plata, Buenos Aires

Fundación Respirar ( Site 0201), Buenos Aires, Buenos Aires F.D.

Centro Privado de RMI Rio Cuarto ( Site 0207), Río Cuarto, Córdoba Province

Instituto de Oncología de Rosario ( Site 0208), Rosario, Santa Fe Province

Instituto Alexander Fleming ( Site 0202), CABA

Hospital Italiano de Córdoba ( Site 0206), Córdoba

Australia

Blacktown Hospital-Blacktown Cancer and Haematology Centre - Medical Oncology ( Site 2300), Blacktown, New South Wales

Chris O'Brien Lifehouse ( Site 2302), Camperdown, New South Wales

Monash Medical Centre ( Site 2301), Clayton, Victoria

The Alfred Hospital ( Site 2305), Melbourne, Victoria

Brazil

Hospital de Câncer de Recife ( Site 0302), Recife, Pernambuco

Liga Norte Riograndense Contra o Câncer ( Site 0301), Natal, Rio Grande do Norte

Hospital do Câncer Mãe de Deus ( Site 0300), Porto Alegre, Rio Grande do Sul

Instituto de Oncologia Saint Gallen ( Site 0308), Santa Cruz do Sul, Rio Grande do Sul

ANIMI - Unidade de Tratamento Oncologico ( Site 0306), Lages, Santa Catarina

Hospital Paulistano ( Site 0304), São Paulo

Canada

The Moncton Hospital ( Site 0101), Moncton, New Brunswick

Chile

CIDO SpA ( Site 0408), Temuco, Araucania

FALP ( Site 0400), Santiago, Region M. de Santiago

Oncovida ( Site 0402), Santiago, Region M. de Santiago

Centro de Oncología de Precisión ( Site 0410), Santiago, Region M. de Santiago

Clínica MEDS La Dehesa ( Site 0405), Santiago, Region M. de Santiago

Bradfordhill ( Site 0401), Santiago, Region M. de Santiago

China

Anhui Provincial Cancer Hospital ( Site 3140), Hefei, Anhui

Cancer Hospital Chinese Academy of Medical Sciences ( Site 3100), Beijing, Beijing Municipality

Peking University People's Hospital. ( Site 3138), Beijing, Beijing Municipality

The First Affiliated Hospital of Chongqing Medical University ( Site 3101), Chongqing, Chongqing Municipality

Chongqing Three Gorges Central Hospital's ( Site 3128), Wanzhou, Chongqing Municipality

The First Affiliated hospital of Xiamen University ( Site 3120), Fujian, Fujian

Sun Yat-Sen University Cancer Center ( Site 3102), Guangzhou, Guangdong

Jiangmen Center Hospital ( Site 3132), Jiangmen, Guangdong

Guangxi Medical University Affiliated Tumor Hospital ( Site 3118), Nanning, Guangxi

Henan Cancer Hospital ( Site 3108), Zhengzhou, Henan

Xiangyang Central Hospital ( Site 3123), Xiangyang, Hubei

Hunan Cancer Hospital ( Site 3134), Changsha, Hunan

Colombia

Instituto de Cancerología-Oncology ( Site 0503), Medellín, Antioquia

FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0502), Bogotá, Bogota D.C.

Instituto Nacional De Cancerologia ( Site 0504), Bogotá, Bogota D.C.

Sociedad De Oncología y Hematología Del Cesar SAS ( Site 0501), Valledupar, Cesar Department

IMAT S.A.S ( Site 0500), Montería, Departamento de Córdoba

France

CHRU de Brest ( Site 0904), Brest, Finistere

CENTRE LEON BERARD ( Site 0900), Lyon, Rhone

Centre de Lutte Contre le Cancer - Centre Henri Becquerel Normandie Rouen ( Site 0901), Rouen, Seine-Maritime

Gustave Roussy ( Site 0903), Villejuif, Val-de-Marne

Germany

Universitaetsklinikum des Saarlandes-Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedi ( Site 1003), Homburg, Saarland

Greece

General Hospital of Athens "Laiko" ( Site 1105), Athens, Attica

Aretaieio Hospital ( Site 1103), Athens, Attica

University General Hospital of Heraklion ( Site 1102), Heraklion, Irakleio

European Interbalkan Medical Center-Oncology Department ( Site 1101), Thessaloniki

Hong Kong

Prince of Wales Hospital ( Site 3301), Hong Kong

Queen Mary Hospital ( Site 3300), Pokfulam

Hungary

Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 1200), Kecskemét, Bács-Kiskun county

Szabolcs Szatmár Bereg Vármegyei Oktatókórház Oncoradiology ( Site 1203), Nyíregyháza, Szabolcs-Szatmár-Bereg

Israel

Rambam Health Care Campus ( Site 1401), Haifa

Shaare Zedek Medical Center ( Site 1406), Jerusalem

Hadassah Medical Center ( Site 1404), Jerusalem

Sheba Medical Center ( Site 1400), Ramat Gan

Italy

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII ( Site 1507), Bergamo, Lombardy

Istituto Europeo di Oncologia IRCCS ( Site 1508), Milan, Lombardy

Ospedale San Raffaele. ( Site 1502), Milan

Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1501), Milan

Istituto Nazionale Tumori IRCCS Fondazione Pascale-S.C. Oncologia Clinica Sperimentale di Senologia ( Site 1506), Naples

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1500), Roma

Japan

Aichi Cancer Center ( Site 3200), Nagoya, Aichi-ken

Nagoya City University Hospital ( Site 3210), Nagoya, Aichi-ken

National Hospital Organization Hokkaido Cancer Center ( Site 3215), Sapporo, Hokkaido

Kansai Medical University Hospital ( Site 3213), Hirakata, Osaka

Kindai University Hospital ( Site 3204), Sakai, Osaka

Shizuoka Cancer Center ( Site 3202), Sunto-gun, Shizuoka

National Cancer Center Hospital ( Site 3206), Chūō, Tokyo

Toranomon Hospital ( Site 3205), Minato, Tokyo

Showa Medical University Hospital ( Site 3209), Shinagawa, Tokyo

Akita University Hospital ( Site 3207), Akita

Chiba Cancer Center ( Site 3203), Chiba

National Hospital Organization Kyushu Cancer Center ( Site 3208), Fukuoka

Fukushima Medical University Hospital ( Site 3212), Fukushima

Mexico

CIO - Centro de Inmuno-Oncología de Occidente ( Site 0600), Guadalajara, Jalisco

Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 0604), Monterrey, Nuevo León

Cuidados Oncologicos. ( Site 0605), Querétaro City, Querétaro

Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 0602), Chihuahua City

Centro de Investigacion Clinica de Oaxaca ( Site 0601), Oaxaca City

Poland

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 1600), Warsaw, Masovian Voivodeship

Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku-Oncologii, Chemioterapii ( Site 1616), Słupsk, Pomeranian Voivodeship

Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onko ( Site 1614), Olsztyn, Warmian-Masurian Voivodeship

Salve Medica sp. z o.o. sp. k. ( Site 1615), Lodz, Łódź Voivodeship

South Korea

Seoul National University Bundang Hospital ( Site 2703), Seongnam, Kyonggi-do

Gangnam Severance Hospital, Yonsei University Health System ( Site 2701), Gangnam-gu, Seoul

Samsung Medical Center ( Site 2704), Gangnam-gu, Seoul

Seoul National University Hospital ( Site 2702), Jongno-Gu, Seoul

Severance Hospital Yonsei University Health System ( Site 2700), Seoul

Asan Medical Center ( Site 2705), Seoul

Spain

Institut Català d'Oncologia (ICO) - Badalona ( Site 1823), Badalona, Barcelona

Hospital Universitario Marques de Valdecilla ( Site 1825), Santander, Cantabria

CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 1820), A Coruña, La Coruna

Hospital Clinic de Barcelona ( Site 1821), Barcelona

Hospital Universitario Ramon y Cajal ( Site 1824), Madrid

Hospital Clinico San Carlos... ( Site 1822), Madrid

Hospital Universitario Virgen de Valme ( Site 1826), Seville

Taiwan

Ditmanson Medical Foundation Chia-Yi Christian Hospital ( Site 2806), Chiayi City, Chiayi

Taichung Veterans General Hospital ( Site 2803), Taichung

National Cheng Kung University Hospital ( Site 2804), Tainan

Chi-Mei Medical Center ( Site 2805), Tainan

National Taiwan University Hospital ( Site 2800), Taipei

MacKay Memorial Hospital ( Site 2802), Taipei

National Taiwan University Cancer Center (NTUCC) ( Site 2801), Taipei

Thailand

Faculty of Medicine Siriraj Hospital ( Site 2921), Bangkoknoi, Bangkok

Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 2924), Dusit, Bangkok

Ramathibodi Hospital. ( Site 2923), Ratchathewi, Bangkok

Songklanagarind Hospital ( Site 2922), Hat Yai, Changwat Songkhla

Maharaj Nakorn Chiang Mai Hospital ( Site 2925), Muang, Chiang Mai

Turkey (Türkiye)

Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi ( Site 2107), Adana

Hacettepe Universite Hastaneleri ( Site 2100), Ankara

Memorial Ankara Hastanesi ( Site 2106), Ankara

Ankara Bilkent Şehir Hastanesi ( Site 2105), Ankara

Dicle Üniversitesi ( Site 2102), Diyarbakır

Koç Üniversitesi Hastanesi ( Site 2104), Istanbul

Mersin Sehir Eğitim ve Araştırma Hastanesi ( Site 2103), Mersin

Recep Tayyip Erdogan University Training and Research Hospital ( Site 2108), Rize

Samsun Medical Park Hastanesi ( Site 2109), Samsun

United Kingdom

St Bartholomew s Hospital ( Site 2200), London, London, City of

Leicester Royal Infirmary ( Site 2205), Leicester

The Christie NHS Foundation Trust ( Site 2208), Manchester

Trial locations(168 sites)

Interested in joining?